Su-jin Yang

Dr. Su-jin Yang

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2024 in Cosmetics
Verified
Journal Article
Open access
PDF file
Trang Thi Minh NguyenTrang Thi Minh Nguyen
Trang Thi Minh Nguyen
EYEun-Ji Yi
Eun-Ji Yi
XJXiangji Jin
Xiangji Jin
ZQZHENG QIWEN
ZHENG QIWEN
SPSe-jig Park
Se-jig Park
Tae Hoo YiTae Hoo Yi
Tae Hoo Yi
Dynamic wrinkle reduction continues to challenge aesthetic dermatology, predominantly addressed through Botulinumtoxin (Botox) injections. Despite Botox’s robust efficacy with up to an 80% reduction in wrinkle visibility within just one week, its invasive administration and specific mechanism of soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) complex inhibition prompt the exploration of safer, non-invasive alternatives. This review critically assesses recent innovations in non-invasive effects, with a focus on peptides and botanical extracts that exhibit a diverse array of mechanisms including SNARE complex inhibition, modulation of calcium and sodium channels, and interactions with acetylcholine receptors, contributing to their effectiveness in muscle relaxation on dynamic wrinkle approaches. Noteworthy peptides such as Argireline and SYN-Ake replicate the neuromodulatory effects of Botox, achieving up to a 52% reduction in wrinkles within four weeks without injections. Moreover, botanical extracts meet the rising demand for clean beauty solutions by enhancing skin elasticity and health through gentle yet potent mechanisms. However, the main concern with peptides is their low absorption rate, with only six clinical validations regarding Botox-like peptide anti-wrinkle efficacy available. These advancements not only deepen our understanding of cosmetic dermatology but also significantly influence market dynamics and consumer behavior, underscoring their pivotal role in redefining the future landscape of anti-aging effects.

10 January 2025 in Molecules
Verified
Journal Article
Open access
PDF file
ZQZHENG QIWEN
ZHENG QIWEN
XJXiangji Jin
Xiangji Jin
Trang Thi Minh NguyenTrang Thi Minh Nguyen
Trang Thi Minh Nguyen
EYEun-Ji Yi
Eun-Ji Yi
SPSe-jig Park
Se-jig Park
Tae Hoo YiTae Hoo Yi
Tae Hoo Yi
The decline in autophagy disrupts homeostasis in skin cells, leading to oxidative stress, energy deficiency, and inflammation—all key contributors to skin photoaging. Consequently, activating autophagy has become a focal strategy for delaying skin photoaging. Natural plants are rich in functional molecules and widely used in the development of anti-photoaging cosmetics. Hedyotis diffusa (HD), as a medicinal plant, is renowned for its anti-inflammatory and anticancer properties; however, its effects on skin photoaging remain unclear. This study investigates HD’s potential to counteract skin photoaging by restoring mitochondrial autophagy in keratinocytes. We used HPLC to detect the main chemical components in HD and, using a UVB-induced photoaging model in HaCaT keratinocytes, examined the effects of HD on reactive oxygen species (ROS) levels, Ca2+ concentration, mitochondrial membrane potential (MMP), apoptosis, and the cell cycle. Cellular respiration was further evaluated with the Seahorse XFp Analyzer, and RT-PCR and Western blotting were used to analyze the impact of HD on mitochondrial autophagy-related gene expression and signaling pathways. Our findings indicate that HD promotes autophagy by modulating the PI3K/AKT/mTOR and PINK/PARK2 pathways, which stabilizes mitochondrial quality, maintains MMP and Ca2+ balance, and reduces cytochrome c release. These effects relieve cell cycle arrest and prevent apoptosis associated with an increased BAX/BCL-2 ratio. Thus, HD holds promise as an effective anti-photoaging ingredient with potential applications in the development of cosmetic products.

11 March 2025 in Biology
Verified
Journal Article
Open access
PDF file
SYSu-jin Yang
Su-jin Yang
Trang Thi Minh NguyenTrang Thi Minh Nguyen
Trang Thi Minh Nguyen
XJXiangji Jin
Xiangji Jin
ZQZHENG QIWEN
ZHENG QIWEN
SPSe-jig Park
Se-jig Park
Tae Hoo YiTae Hoo Yi
Tae Hoo Yi
Sexual dysfunction, influenced by hormonal imbalances, psychological factors, and chronic diseases, affects a significant portion of the population. Probiotics, known for their beneficial effects on gut microbiota, have emerged as potential therapeutic agents for improving sexual health. This systematic review evaluates the impact of probiotics on sexual function, hormonal regulation, and reproductive outcomes. A comprehensive search identified 3308 studies, with 12 meeting the inclusion criteria—comprising 10 randomized controlled trials (RCTs) and 2 in vivo and in vitro studies. Probiotic interventions were shown to significantly improve sexual function, particularly in women undergoing antidepressant therapy (p < 0.05). Significant improvements in Female Sexual Function Index (FSFI) scores were observed, with combined treatments such as Lactofem with Letrozole and Lactofem with selective serotonin reuptake inhibitors (SSRIs) demonstrating a 10% biochemical and clinical pregnancy rate compared to 0% in the control group (p = 0.05). Probiotic use was also associated with a 66% reduction in menopausal symptoms, increased sperm motility (36.08%), viability (46.79%), and morphology (36.47%). Probiotics also contributed to favorable hormonal changes, including a reduced luteinizing hormone (LH) to follicle-stimulating hormone (FSH) ratio (from 3.0 to 2.5, p < 0.05) and increased testosterone levels. Regarding reproductive outcomes, probiotic use was associated with higher pregnancy rates in women undergoing fertility treatments and improvements in sperm motility, viability, and morphology in men. This review highlights the promising role of probiotics in addressing sexual dysfunction and reproductive health, suggesting their potential as adjunctive treatments for conditions such as depression and infertility. Further research is needed to better understand the underlying mechanisms of these beneficial effects.

8 April 2025 in Antibiotics
Verified
Journal Article
Open access
PDF file
GYGyeong-seon Yi
Gyeong-seon Yi
XJXiangji Jin
Xiangji Jin
ZQZHENG QIWEN
ZHENG QIWEN
Trang Thi Minh NguyenTrang Thi Minh Nguyen
Trang Thi Minh Nguyen
SYSu-jin Yang
Su-jin Yang
Tae Hoo YiTae Hoo Yi
Tae Hoo Yi
Background/Objectives: Multidrug-resistant (MDR) pathogens pose a critical challenge in infection treatment. Pediococcus pentosaceus (P. pentosaceus) is known for its antimicrobial activity; however, studies on its effects against MDR pathogens remain limited. This study aimed to evaluate the antimicrobial and biological activities of P. pentosaceus PMY2, isolated from fermented porcine colostrum yogurt, against MDR pathogens, including Staphylococcus aureus (S. aureus), Pseudomonas aeruginosa (P. aeruginosa), and Escherichia coli (E. coli). Methods: The antimicrobial, anti-inflammatory, and cytotoxic effects of P. pentosaceus PMY2 were evaluated in vitro. In addition, IL-6 and TNF-α levels were analyzed using an ELISA kit. Results: The MIC value against S. aureus KCTC 3881 and MRSA (CCARM 3089) was 0.31 mg/mL, while the MBC values were 0.63 mg/mL and 2.5 mg/mL, respectively. At MIC, biofilm formation was inhibited by 62.2% in S. aureus KCTC 3881 and by 51.5% in MRSA. CFS exhibited low cytotoxicity in RAW 264.7 macrophages and significantly reduced NO production, IL-6, and TNF-α levels, indicating strong anti-inflammatory effects. Conclusions: These findings suggest that P. pentosaceus PMY2 exhibited excellent antimicrobial and anti-inflammatory activity against MDR pathogens, demonstrating its potential as a natural antimicrobial agent. These results indicate that PMY2 CFS could be a promising candidate for addressing antibiotic resistance issues.

22 November 2024 in Chemistry
Verified
Journal Article
Open access
PDF file
XJXiangji Jin
Xiangji Jin
Trang Thi Minh NguyenTrang Thi Minh Nguyen
Trang Thi Minh Nguyen
EYEun-Ji Yi
Eun-Ji Yi
ZQZHENG QIWEN
ZHENG QIWEN
SPSe-jig Park
Se-jig Park
Tae Hoo YiTae Hoo Yi
Tae Hoo Yi
Background: Reflecting the increasing interest and research on living a healthy life as society ages, there has been a surge in attention and studies on photodamage. Probiotics have been studied for their ability to enhance skin integrity and provide protection from ultraviolet radiation (UVR). However, despite this, extensive research has revealed various issues and side effects, prompting increased interest in alternative options that can effectively and safely protect the skin. We focused on postbiotics as a promising solution for photodamage, aiming to demonstrate their potential as a safe and stable alternative to probiotics. Methods: We investigated papers on “skin aging” or “photoaging” and “probiotics” or “postbiotics” from 2013 to 2023 using the Web of Science, PubMed, and Scopus. Additionally, we compared and analyzed publications, authors, countries, keywords, and citations using the VOS viewer program. Results: According to our search results, the majority of papers on photodamage and probiotics were published in PubMed, with the United States leading in publication volume among countries. The most common keywords were “photodamage” and “skin”. The most cited paper recorded 470 citations. Furthermore, upon focused analysis of five papers on postbiotics and photodamage, postbiotics demonstrated preventive and protective effects against skin photodamage. Conclusions: Postbiotics for photodamage show potential as a safe and stable alternative to probiotics. However, research on postbiotics and photodamage remains limited, and additional studies and long-term tracking are essential to substantiate our claims.

6 February 2025 in Applied Sciences
Verified
Journal Article
Open access
PDF file
XJXiangji Jin
Xiangji Jin
ZQZHENG QIWEN
ZHENG QIWEN
Trang Thi Minh NguyenTrang Thi Minh Nguyen
Trang Thi Minh Nguyen
SYSu-jin Yang
Su-jin Yang
SPSe-jig Park
Se-jig Park
Tae Hoo YiTae Hoo Yi
Tae Hoo Yi
Urogenital infections impact millions of individuals globally each year, with vulvovaginal candidiasis (VVC) being one of the most prevalent conditions affecting women. Candida albicans is the primary pathogen responsible for VVC. The utilization of probiotics as an alternative therapeutic approach to antibiotics in managing such infections has gained increasing attention. This study aimed to evaluate the potential of THY-F51, a lactic acid bacterium isolated from kiwi, as a probiotic to support vaginal health through its antifungal, anti-biofilm, and anti-inflammatory properties against C. albicans. The identification of THY-F51 was confirmed through 16S rRNA gene sequencing. A series of evaluations were performed to determine its antifungal efficacy against C. albicans, biofilm-inhibitory activity, antioxidant properties, and effects on inflammatory cytokines. Cytotoxicity assays and assessments of bacterial survival under vaginal pH conditions (pH 3.8–4.5) were also conducted. The results demonstrated that THY-F51, identified as Leuconostoc citreum, exhibited potent antifungal activity against C. albicans, with an MIC of 1.25 mg/mL and an MFC of 2.5 mg/mL. Furthermore, THY-F51 displayed a strong inhibition of C. albicans biofilm formation, as well as notable antioxidant activity in the supernatant. Additionally, THY-F51 demonstrated high survival rates under vaginal pH conditions, an absence of cytotoxic effects, and a significant reduction in C. albicans adhesion to HeLa cells. Moreover, THY-F51 effectively suppressed C. albicans-induced inflammatory cytokines, including TNF-α, IL-1β, IL-6, and IL-8. These findings suggest that THY-F51, isolated from kiwi, holds substantial promise as a safe and effective probiotic for reducing vaginal inflammation and promoting vaginal health.